Grant Amount: Approximate Total Fiscal Year Funding: $2,500,000. Following earlier PEPFAR funded work, the intent of this FOA is to consolidate earlier efforts and to ensure that complete technical skills have been built and will remain sustained for the future. Each year, the Ministry and National Institute for Health gain new skill in strategic information (SI) and continue to grow as an evidence based public health institute.
Grant Amount: Approximate Total Fiscal Year Funding: $77,120,323; Approximate Total Project Period Funding: $385,601,610. The Centers for Disease Control and Prevention (CDC) announces the availability of Fiscal Year (FY) 2015 funds to implement funding opportunity announcement (FOA) CDC-RFA-PS15-1501 Tuberculosis (TB) Elimination and Laboratory Cooperative Agreement (CoAg). TB CoAg funds support TB Prevention and Control (P&C) activities, TB programs’ Human Resources Development (HRD) activities, and Public Health Laboratory Strengthening activities according to formulas that reflect TB
Grant Amount: Approximate Total Fiscal Year Funding: approximately $4,000,000; Approximate Total Project Period Funding: approximately $15,000,000. CDC seeks to support state and local public health efforts to increase the prevention effectiveness of public health interventions. Timely models and economic analyses support both of these goals.
Grant Amount: Approximate Current Fiscal Year Funding: $1,000,000. The goal and objectives of the program in Rwanda is to enhance the engagement and effectiveness of local, civil society organizations that work with and represent People Living with Disabilities (PLWDs) to promote country ownership, effectiveness, and sustainability of health systems in addressing the country HIV/AIDS response. Objectives: 1.
Grant Amount: Approximate Total Fiscal Year Funding: Category A: $700,000.00 and Category B: $700,000.00; Approximate Total Project Period Funding: Category A: up to $3,500,000 and Category B: up to $3,500,000.
Grant Amount: Approximate Current Fiscal Year Funding: $25,000,000; Approximate Total Project Period Funding: $125,000,000. The goals of this FOA are to: (1) Support the implementation of country-led, population-based HIV impact assessments to measure HIV-relevant services uptake and health outcomes and to monitor and inform policy and programming. (2) Strengthen host country capacity and skills to conduct population-based HIV impact assessments. (3) Use cost-effective, sustainable approaches and design elements leveraging current and evolving technologies.
Grant Amount: Approximate Total Fiscal Year Funding: $4,400,000 (for first year); Approximate Total Project Period Funding: $20,000,000. Despite new FDA-approved, curative therapies, recent data indicate that only 50% of HCV-infected persons in the United States have been tested for HCV. Of these, 32%-38% are referred for care, 7%-11% are treated, and 5%-6% achieve virologic cure; these low proportions reflect gaps in health-care delivery at every stage of the HCV continuum of care.
Grant Amount: Estimated total funding available including direct and indirect costs for first year $600,000; Estimated total funding available including direct and indirect costs for entire project period $1,800,000. The purpose and overarching goal of this cooperative agreement is to address the high prevalence of viral hepatitis C infection by developing and implementing an integrated approach for detection, prevention, care and treatment of Hepatitis C infection among young (18-30 year old), non-urban people who inject drugs (PWID).
This award will be a continuation of funds intended only for grantees previously awarded under PS13-1308: Promoting Adolescent Health through School-Based HIV/STD Prevention and School-Based Surveillance.